Immune Response to : A Narrative Review

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2019 Sep 12

PMID 31508399

Citations 134

Authors

Maurizio de Martino

Lorenzo Lodi

Luisa Galli

Elena Chiappini

Affiliations

Soon will be listed here.

Abstract

The encounter between (Mtb) and the host leads to a complex and multifaceted immune response possibly resulting in latent infection, tubercular disease or to the complete clearance of the pathogen. Macrophages and CD4 T lymphocytes, together with granuloma formation, are traditionally considered the pillars of immune defense against Mtb and their role stands out clearly. However, there is no component of the immune system that does not take part in the response to this pathogen. On the other side, Mtb displays a complex artillery of immune-escaping mechanisms capable of responding in an equally varied manner. In addition, the role of each cellular line has become discussed and uncertain further than ever before. Each defense mechanism is based on a subtle balance that, if altered, can lean to one side to favor Mtb proliferation, resulting in disease progression and on the other to the host tissue damage by the immune system itself. Through a brief and complete overview of the role of each cell type involved in the Mtb response, we aimed to highlight the main literature reviews and the most relevant studies in order to facilitate the approach to such a complex and changeable topic. In conclusion, this narrative mini-review summarizes the various immunologic mechanisms which modulate the individual ability to fight Mtb infection taking in account the major host and pathogen determinants in the susceptibility to tuberculosis.

Citing Articles

Development of a multi-epitope vaccine candidate to combat SARS-CoV-2 and dengue virus co-infection through an immunoinformatic approach.

Mandal S, Chanu W, Natarajaseenivasan K Front Immunol. 2025; 16:1442101.

PMID: 40079004 PMC: 11897530. DOI: 10.3389/fimmu.2025.1442101.

Serum chitotriosidase activity in South African patients with sarcoidosis and tuberculosis.

Morar R, Sinclair I, Feldman C Afr J Thorac Crit Care Med. 2025; 30(4):e1832.

PMID: 40041418 PMC: 11874180. DOI: 10.7196/AJTCCM.2024.v30i4.1832.

Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation.

Dinh P, Tran C, Dinh T, Ha H, Utegenova A, Ali A Biochem Biophys Rep. 2025; 41:101952.

PMID: 40034257 PMC: 11875834. DOI: 10.1016/j.bbrep.2025.101952.

Single-cell transcriptome analysis reveals the dysregulated monocyte state associated with tuberculosis progression.

Ma R, Yang W, Guo W, Zhang H, Wang Z, Ge Z BMC Infect Dis. 2025; 25(1):210.

PMID: 39939918 PMC: 11823163. DOI: 10.1186/s12879-025-10612-3.

The Association Between Tuberculosis and Osteoporosis: A Systematic Review and Meta-Analysis.

Charatcharoenwitthaya K, Suntrapiwat K, Wongtrakul W Cureus. 2025; 16(12):e76397.

PMID: 39867096 PMC: 11762585. DOI: 10.7759/cureus.76397.

References

Caruso A, Serbina N, Klein E, TRIEBOLD K, Bloom B, Flynn J . Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol. 1999; 162(9):5407-16. View

Canaday D, Wilkinson R, Li Q, Harding C, Silver R, Boom W . CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol. 2001; 167(5):2734-42. DOI: 10.4049/jimmunol.167.5.2734. View

Casanova J, Abel L . Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002; 20:581-620. DOI: 10.1146/annurev.immunol.20.081501.125851. View

Middleton A, Chadwick M, Nicholson A, Dewar A, Groger R, Brown E . Interaction of Mycobacterium tuberculosis with human respiratory mucosa. Tuberculosis (Edinb). 2002; 82(2-3):69-78. DOI: 10.1054/tube.2002.0324. View

Zhang R, Zheng X, Li B, Wei H, Tian Z . Human NK cells positively regulate gammadelta T cells in response to Mycobacterium tuberculosis. J Immunol. 2006; 176(4):2610-6. DOI: 10.4049/jimmunol.176.4.2610. View

Tan B, Meinken C, Bastian M, Bruns H, Legaspi A, Ochoa M . Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol. 2006; 177(3):1864-71. DOI: 10.4049/jimmunol.177.3.1864. View

Russell D . Who puts the tubercle in tuberculosis?. Nat Rev Microbiol. 2006; 5(1):39-47. DOI: 10.1038/nrmicro1538. View

Stein C, Zalwango S, Malone L, Won S, Mayanja-Kizza H, Mugerwa R . Genome scan of M. tuberculosis infection and disease in Ugandans. PLoS One. 2009; 3(12):e4094. PMC: 2605555. DOI: 10.1371/journal.pone.0004094. View

Cooper A . Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009; 27:393-422. PMC: 4298253. DOI: 10.1146/annurev.immunol.021908.132703. View

10.

Russell D, Cardona P, Kim M, Allain S, Altare F . Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol. 2009; 10(9):943-8. PMC: 2759071. DOI: 10.1038/ni.1781. View

11.

Yuk J, Shin D, Lee H, Yang C, Jin H, Kim K . Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009; 6(3):231-43. DOI: 10.1016/j.chom.2009.08.004. View

12.

Carlos D, Fremond C, Samarina A, Vasseur V, Maillet I, Ramos S . Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection. Infect Immun. 2009; 77(12):5359-68. PMC: 2786437. DOI: 10.1128/IAI.01497-08. View

13.

Ehlers S . DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur J Cell Biol. 2009; 89(1):95-101. DOI: 10.1016/j.ejcb.2009.10.004. View

14.

Cobat A, Gallant C, Simkin L, Black G, Stanley K, Hughes J . Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J Exp Med. 2009; 206(12):2583-91. PMC: 2806605. DOI: 10.1084/jem.20090892. View

15.

Balboa L, Romero M, Yokobori N, Schierloh P, Geffner L, Basile J . Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol Cell Biol. 2010; 88(7):716-26. DOI: 10.1038/icb.2010.22. View

16.

Ringshausen F, Nienhaus A, Schablon A, Schlosser S, Schultze-Werninghaus G, Rohde G . Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis. 2010; 10:220. PMC: 2916913. DOI: 10.1186/1471-2334-10-220. View

17.

Berry M, Graham C, McNab F, Xu Z, Bloch S, Oni T . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466(7309):973-7. PMC: 3492754. DOI: 10.1038/nature09247. View

18.

Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K . PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 2010; 14(6):R220. PMC: 3220038. DOI: 10.1186/cc9354. View

19.

Bustamante J, Arias A, Vogt G, Picard C, Galicia L, Prando C . Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011; 12(3):213-21. PMC: 3097900. DOI: 10.1038/ni.1992. View

20.

Botella H, Peyron P, Levillain F, Poincloux R, Poquet Y, Brandli I . Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe. 2011; 10(3):248-59. PMC: 3221041. DOI: 10.1016/j.chom.2011.08.006. View